Interventional Neuroradiology, West Virginia University Hospital, Morgantown, West Virginia 26508, USA.
J Neurointerv Surg. 2013 Mar;5(2):121-7. doi: 10.1136/neurintsurg-2011-010189. Epub 2012 Feb 18.
Endovascular therapy of acute ischemic stroke is evolving towards thrombectomy devices for vessel recanalization. High rates of revascularization have been reported in stroke device trials. However, the discrepancy between recanalization and outcomes raises the question whether patients with irreversible ischemic injury are being exposed to these interventions. This study evaluated a triage methodology that incorporates perfusion imaging against previous device trials that treated all patients within a certain time frame.
99 consecutive patients were identified with anterior circulation strokes who had undergone endovascular therapy. All patients had a baseline NIHSS score ≥8 and had undergone pre-intervention CT perfusion. Rates of recanalization and functional outcomes were compared with the MERCI, Multi-MERCI and Penumbra trials.
This study's recanalization rate of 55.6% is not significantly different from the 46% for MERCI (p=0.15) and 68% for Multi-MERCI (p=0.08) but was significantly lower than the 82% for the Penumbra trial (p<0.0001). Successfully recanalized patients had a significantly higher good outcome of 67% in this cohort versus 46% in MERCI, 49% in Multi-MERCI and 29% in Penumbra. The rate of futile recanalization was 33% compared with 54% for MERCI, 51% for Multi-MERCI and 71% for Penumbra. A small cerebral blood volume (CBV) abnormality (p<0.0001) and large mean transit time-CBV mismatch (p<0.0001) were strong predictors of a good outcome.
Despite similar or lower recanalization rates, there was a significantly higher rate of good outcomes in the recanalized population and thus a significantly lower rate of futile recanalization in this study versus the device trials, suggesting a role for pre-intervention perfusion imaging for patient selection.
急性缺血性脑卒中的血管内治疗正朝着血管再通的血栓切除术装置发展。在脑卒中设备试验中,已报道了较高的再通率。然而,再通与结果之间的差异提出了这样一个问题,即是否对存在不可逆缺血损伤的患者进行了这些干预。本研究评估了一种分诊方法,该方法将灌注成像纳入其中,与以前的设备试验进行对比,这些试验在一定时间框架内治疗所有患者。
确定了 99 例接受血管内治疗的前循环脑卒中患者。所有患者的基线 NIHSS 评分均≥8,并且接受了术前 CT 灌注。比较了再通率和功能结局与 MERCI、Multi-MERCI 和 Penumbra 试验。
本研究 55.6%的再通率与 MERCI 的 46%(p=0.15)和 Multi-MERCI 的 68%(p=0.08)无显著差异,但明显低于 Penumbra 试验的 82%(p<0.0001)。在本队列中,成功再通的患者有显著更高的良好结局(67%),而 MERCI 为 46%,Multi-MERCI 为 49%,Penumbra 为 29%。无意义再通率为 33%,MERCI 为 54%,Multi-MERCI 为 51%,Penumbra 为 71%。小的脑血容量(CBV)异常(p<0.0001)和大的平均通过时间-CBV 不匹配(p<0.0001)是良好结局的强烈预测因素。
尽管再通率相似或更低,但本研究中再通人群的良好结局率明显更高,因此无意义再通率明显更低,这表明术前灌注成像在患者选择中具有重要作用。